HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$2.50
Day range
$2.31 - $2.50
Year range
$1.24 - $10.20
Market cap
94.32M USD
Avg Volume
405.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.58M | -65.66% |
Net income | -13.82M | 66.99% |
Net profit margin | — | — |
Earnings per share | -0.51 | 84.06% |
EBITDA | -14.57M | 65.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 54.92M | -46.18% |
Total assets | 57.96M | -45.60% |
Total liabilities | 10.59M | 0.84% |
Total equity | 47.37M | — |
Shares outstanding | 38.26M | — |
Price to book | 1.35 | — |
Return on assets | -55.74% | — |
Return on capital | -67.27% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -13.82M | 66.99% |
Cash from operations | -15.52M | -22.17% |
Cash from investing | — | — |
Cash from financing | 29.00K | 200.00% |
Net change in cash | -15.72M | -143.03% |
Free cash flow | -11.73M | 57.02% |
About
Founded
2011
Website
Employees
54